U.S. District Court for the District of Connecticut

States seek approval of $1.05M generic drug price-fixing settlements with Ascend, Mayne and Citron

Forty-eight states and territories asked the U.S. District Court for the District of Connecticut on Oct. 8 to preliminarily approve generic drug price-fixing settlements with Ascend Laboratories, Mayne Pharma and Citron Pharma, according to the states' motion. Ascend will pay $400,000 and Mayne $650,000; Citron, which ceased operations, agreed to non-monetary injunctive and cooperation terms. Connecticut's attorney general said the first trial is set for February 2027 in Hartford.